ClinConnect ClinConnect Logo
Search / Trial NCT04997473

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Aug 2, 2021

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help young patients who are dealing with obesity after having a hematopoietic stem cell transplant (HSCT). The study will use mobile health technology, like an app, to support these patients in making healthier lifestyle changes. Researchers want to see how this intervention can affect their weight, eating habits, and motivation to improve their health.

To participate in the study, candidates must be between 13 and 30 years old, have had a stem cell transplant at least 100 days prior, and have a body mass index (BMI) that shows they are obese. Both boys and girls can join, but they need to be able to read English since the app is only available in that language. If you or someone you know fits these criteria, you might have the opportunity to join this study and receive support in managing weight and improving overall health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study.
  • Both male and female patients will be eligible.
  • Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender.
  • Patients must also be able to read English since the app intervention is only available in English form.
  • Exclusion Criteria:
  • Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study.
  • Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window.
  • Patients whose BMI does not fall under the obese category will be excluded.
  • No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.

About University Of California, Los Angeles

The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.

Locations

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Theodore B Moore, MD

Principal Investigator

UCLA Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials